“…The therapy of Alzheimer's disease with TBO based on its inhibition of Tau protein aggregation is promising [19]. Using optical methods, it was found that the TBO molecule is able to effectively bind to DNA [20][21][22][23][24][25][26], RNA [26][27][28], proteins [19,[29][30][31][32][33][34], silver nanoparticles [6,35,36], silica [15] and cadmium sulfide [37], natural organic matter [38], cyclodextrins [39][40][41], surfactant micelles [40][41][42], chitosan [43], heparin [44], nanotubes [2], fatty acids [45] , polysaccharides [9,[46][47][48] and other polymers [18,49,50]. Numerous experimental optical studies of TBO itself have been carried outaggregation [21,[51][52][53][54], reduction [36,42,[55]…”